| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88296767 | FILING DATE | 02/11/2019 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | ONUOHA, UKACHUKWU FRED |
L.O. ASSIGNED | N30-NOT FOUND |
PUB INFORMATION |
|||
| RUN DATE | 05/13/2020 | ||
| PUB DATE | 09/17/2019 | ||
| STATUS | 730-FIRST EXTENSION - GRANTED | ||
| STATUS DATE | 05/11/2020 | ||
| LITERAL MARK ELEMENT | CTX130 | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | CTX130 |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | CRISPR Therapeutics AG |
| ADDRESS | Aeschenvorstadt 36 Basel, 4051 |
| ENTITY | 99-aktiengesellschaft |
| CITIZENSHIP | Switzerland |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 05/13/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 020 |
| 05/11/2020 | EX1G | S | EXTENSION 1 GRANTED | 019 |
| 05/11/2020 | EXT1 | S | EXTENSION 1 FILED | 018 |
| 05/11/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 017 |
| 11/12/2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 016 |
| 09/17/2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 015 |
| 09/17/2019 | PUBO | A | PUBLISHED FOR OPPOSITION | 014 |
| 08/28/2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 013 |
| 08/13/2019 | ALIE | A | ASSIGNED TO LIE | 012 |
| 08/06/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 011 |
| 08/02/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 010 |
| 08/01/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 009 |
| 08/01/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 008 |
| 04/26/2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 007 |
| 04/26/2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 006 |
| 04/24/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 005 |
| 04/24/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 004 |
| 04/24/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 003 |
| 04/19/2019 | DOCK | D | ASSIGNED TO EXAMINER | 002 |
| 03/05/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Jess M. Collen |
| CORRESPONDENCE ADDRESS | Jess M. Collen COLLEN, Intellectual Property Law, P.C. THE HOLYOKE-MANHATTAN BUILDING 80 South Highland Avenue Ossining NY 10562 |
| DOMESTIC REPRESENTATIVE | Jess M. Collen |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | CRISPR Therapeutics AG |
| ADDRESS | Aeschenvorstadt 36 Basel, 4051 |
| ENTITY | 99-aktiengesellschaft |
| CITIZENSHIP | Switzerland |